Biogen Inc. buy Piper Sandler
Start price
14.02.24
/
50%
€207.20
Target price
14.02.25
€302.90
Performance (%)
-6.15%
Price
26.07.24
€194.45
Summary
This prediction is currently active. With a performance of -6.15%, the BUY prediction for Biogen Inc. by Piper_Sandler is down slightly. This prediction currently runs until 14.02.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -6.604% | -6.604% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Piper_Sandler for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Piper Sandler from $350.00 to $325.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat